First Trust Nasdaq Pharmaceuticals ETF
FTXH
FTXH
20 hedge funds and large institutions have $19.4M invested in First Trust Nasdaq Pharmaceuticals ETF in 2022 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
25% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 4
Holders
20
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$6.33M | |
| 2 | +$4.21M | |
| 3 | +$918K | |
| 4 |
WFA
WMG Financial Advisors
Knoxville,
Tennessee
|
+$848K |
| 5 |
Jane Street
New York
|
+$397K |
Top Sellers
| 1 | -$723K | |
| 2 | -$538K | |
| 3 | -$251K | |
| 4 |
LPL Financial
San Diego,
California
|
-$239K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$60.5K |